Corticosteroid Eye Drop not checked

Ocugen

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Eye drop to be administered after Brimonidine in treatment arm 1”In the company’s words, NCT03418727 on ClinicalTrials.gov
Tested for
Dry Eye
Main trialPhase 2
“To evaluate the tolerability and preliminary efficacy of Brimonidine eye drops (with and without corticosteroid eye drops) for the treatment of Dry Eye Disease (DED).”In the company’s words, NCT03418727 on ClinicalTrials.gov

Other drugs for Dry Eye

All 44 drugs for Dry Eye

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 2Completed 29 Mar 2018 Dry Eye Disease Study With Brimonidine
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Corticosteroid Eye Drop

Following is part of Solo: you see every change to Corticosteroid Eye Drop the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in